Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Appointed CFO
Director departure
Appointed director
Notes underwriting agrmnt
|
|
ORAGENICS INC (OGEN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/29/2023 |
8-K
| Asset disposition |
| 06/27/2016 |
8-K
| Asset disposition, Resignation/termination of a director|
Docs:
|
"Promissory Note",
"Guaranty",
"Transition Services Agreement",
"Sublease",
"Oragenics Announces Completion of Sale of Consumer Probiotic Business Tampa, FL - Oragenics, Inc. , a leader in the development of novel antibiotics against infectious disease and developing effective treatments for oral mucositis, today announced it has completed the sale of its Consumer Probiotic Business to ProBiora Health, LLC, an entity owned by Ms. Christine L. Koski. The purchase price was $1,700,000 in cash of which $1,250,000 was paid at closing and $450,000 is payable on or before July 31, 2016. ProBiora Health will also assume certain liabilities and the purchase price is not subject to adjustment. ProBiora Health will also be obligated to pay the Company contingent consideration annually over a 10 year period based on a percentage of sales of products using the Purchased Assets..." |
|
|
|